We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+1.75%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
-$76.2M
(-0.7%)
Cap. Flow
-$178M
Cap. Flow
% of AUM
-1.64%
Top 10 Holdings %
Top 10 Hldgs %
28.27%
Holding
568
New
2
Increased
152
Reduced
375
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$113M |
| 2 |
Amazon
AMZN
|
+$16.9M |
| 3 |
Snowflake
SNOW
|
+$15.1M |
| 4 |
Palantir
PLTR
|
+$7.78M |
| 5 |
Analog Devices
ADI
|
+$7.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$22.8M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$22.7M |
| 3 |
Microsoft
MSFT
|
+$16.2M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$12.5M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.75% |
| 2 | Financials | 14.45% |
| 3 | Healthcare | 13.61% |
| 4 | Consumer Discretionary | 11.84% |
| 5 | Communication Services | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Chubb
CB
$136B
| $21.6M | 0.2% |
124,353
-1,700
| -1% | -$298K |
|
102
Micron Technology
MU
$1.01T
| $21.5M | 0.2% |
303,309
-10,500
| -3% | -$788K |
|
103
Lam Research
LRCX
$385B
| $21.4M | 0.2% |
375,370
-13,000
| -3% | -$791K |
|
104
Exelon
EXC
$47.1B
| $20.7M | 0.19% |
601,322
-285,868
| -32% | -$9.77M |
|
105
Edwards Lifesciences
EW
$51.2B
| $20.4M | 0.19% |
180,638
-10,265
| -5% | -$1.17M |
|
106
Colgate-Palmolive
CL
$74.4B
| $20.3M | 0.19% |
269,194
-8,400
| -3% | -$667K |
|
107
Crown Castle
CCI
$32.3B
| $20.2M | 0.19% |
116,290
-3,700
| -3% | -$715K |
|
108
Cigna
CI
$71.5B
| $20M | 0.18% |
100,154
-2,400
| -2% | -$522K |
|
109
Mercado Libre
MELI
$97.5B
| $20M | 0.18% |
11,894
+200
| +2% | +$346K |
|
110
Becton Dickinson
BDX
$47B
| $19.9M | 0.18% |
82,867
-2,162
| -3% | -$530K |
|
111
HCA Healthcare
HCA
$88.7B
| $19.5M | 0.18% |
80,288
-4,400
| -5% | -$1.08M |
|
112
Boston Scientific
BSX
$69.2B
| $19.3M | 0.18% |
445,885
-14,900
| -3% | -$659K |
|
113
General Motors
GM
$78.2B
| $19.3M | 0.18% |
366,389
-6,600
| -2% | -$351K |
|
114
Aon
AON
$76.4B
| $19.2M | 0.18% |
67,056
+1,800
| +3% | +$484K |
|
|
115
Snowflake
SNOW
$110B
| $19.1M | 0.18% |
63,300
+53,200
| +527% | +$15.1M |
|
116
CME Group
CME
$95.2B
| $19.1M | 0.18% |
98,722
+1,700
| +2% | +$344K |
|
117
Snap
SNAP
$8.97B
| $18.5M | 0.17% |
251,000
-600
| -0.2% | -$43.3K |
|
118
Autodesk
ADSK
$50.7B
| $18.3M | 0.17% |
64,298
-2,500
| -4% | -$765K |
|
119
Ecolab
ECL
$80.3B
| $18.2M | 0.17% |
87,140
-5,384
| -6% | -$1.18M |
|
120
Intercontinental Exchange
ICE
$84.1B
| $18M | 0.17% |
156,537
+5,116
| +3% | +$607K |
|
121
Regeneron Pharmaceuticals
REGN
$79.1B
| $17.8M | 0.16% |
29,456
-300
| -1% | -$186K |
|
|
FISV
122
Fiserv Inc
FISV
$28.9B
| $17.7M | 0.16% |
163,069
+400
| +0.2% | +$44.7K |
|
123
Uber
UBER
$139B
| $17.6M | 0.16% |
393,480
+62,800
| +19% | +$2.74M |
|
124
Moody's
MCO
$83.8B
| $17.3M | 0.16% |
48,794
-900
| -2% | -$339K |
|
125
Equinix
EQIX
$104B
| $17M | 0.16% |
21,464
-2,700
| -11% | -$2.24M |
|
Similar funds
MMH
VARA
SC
CB
MIC
GT
Fjarde Ap-fonden's Q3 2021 Portfolio in Review
As of Q3 2021, Fjarde Ap-fonden held 568 positions worth $10.8B, down 0.7% from $10.9B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 1.9%. Fjarde Ap-fonden opened 2 new positions and exited 9, leaving the 568-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Fjarde Ap-fonden's largest Q3 2021 buy was DoorDash: 26,300 shares worth $5.42M.
- Fjarde Ap-fonden added most to iShares MSCI USA Value Factor ETF in Q3 2021, an estimated $113M increase.
- Fjarde Ap-fonden's biggest Q3 2021 reduction was Apple, cutting an estimated $22.8M.
- Fjarde Ap-fonden fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $12.5M.
- Fjarde Ap-fonden's ten largest holdings make up 28% of its $10.8B portfolio in Q3 2021.
- Fjarde Ap-fonden opened 2 new positions and closed 9 in Q3 2021.
- Fjarde Ap-fonden's portfolio value fell 0.7% quarter-over-quarter to $10.8B.
Based on Fjarde Ap-fonden's 13F filing for Q3 2021, filed 15 Nov 2021.